XML 22 R15.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Leases | 3 Months Ended
--- | ---
Mar. 31, 2024
Lessee Disclosure [Abstract] |
Leases |
7. | Leases
Operating Leases Gyre Pharmaceuticals’ corporate headquarters, a 968 square meter office space, is situated in Beijing, PRC, with the lease expiring in June 2024. Additionally, a laboratory center spanning approximately 640 square meters was leased in Shanghai, PRC, which expired in November 2023. In 2022, the Company secured a new lease for an office space of approximately 180 square meters in Zhengzhou, PRC, with the lease set to expire in August 2024. In November 2023, the Company also secured a new lease for its U.S. headquarters in San Diego, California, with the lease set to expire in the first quarter of 2027. The Company also has multiple short-term leased properties used as offices and employee dormitories. The Company recorded a total of $18,000 and $25,000 short-term rent expenses during the three months ended March 31, 2024 and 2023, respectively. The short-term rent expense amounts are recorded in operating expenses in the accompanying condensed consolidated statements of operations and comprehensive income. As of March 31, 2024, the Company recorded an aggregate right-of-use asset of $0.4 million and an aggregate lease liability of $0.3 million in the accompanying condensed consolidated balance sheets. For the three months ended March 31, 2024 and 2023, the Company’s operating lease expense was $0.1 million and $0.1 million, respectively. Variable lease payments for the three months ended March 31, 2024 and 2023 were immaterial. Supplemental cash flow information related to operating leases was as follows (in thousands):
|  | Three Months Ended March 31, |
|  | 2024 |  |  | 2023 |
Cash paid for amounts included in the measurement of lease liabilities |  | $ | 139 |  |  | $ | 127 |
The present value assumptions used in calculating the present value of the lease payments were as follows:
|  | March 31, 2024 |  |  | December 31, 2023 |
Weighted-average remaining lease term |  | 2.7 years |  |  | 2.2 years |
Weighted-average discount rate |  |  | 4.80 | % |  |  | 4.78 | %
As of March 31, 2024, undiscounted future minimum payments under the Company’s operating leases were as follows (in thousands):
|  | Amount |
Remaining in 2024 |  | $ | 85 |
2025 |  |  | 103 |
2026 |  |  | 106 |
Total undiscounted lease payments |  |  | 294 |
Less: imputed interest |  |  | (19 | )
Total lease liabilities |  |  | 275 |
Less: current portion of lease liabilities |  |  | (100 | )
Lease liabilities, net of current portion |  | $ | 175 |
The Company is required to maintain security deposits of $0.4 million in connection with various leases, which amounts are included in other assets, noncurrent on the Company’s condensed consolidated balance sheets. Land Use Rights As of March 31, 2024, the Company held land use rights for two land parcels in Beijing’s Shunyi District, expiring in 2053, and in Cangzhou, Hebei Province, expiring from 2067 to 2071. These parcels, with a combined area of approximately 66,559 square meters, are utilized as manufacturing facilities. As of March 31, 2024, the aggregate recorded land use rights, net assets for these parcels was $1.5 million.

X
- References No definition available. + Details
Name: | us-gaap_LesseeDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration